CLOT
+
Search
Evidence Summaries
Articles
Alerted Articles
Saved Articles
Browse Topics
Evidence Summaries
Member Publications
Hit Parade
Reviews
Original Studies
Clinical Prediction Guides
Prognosis
Most Read
Resources
Evidence-Based Links
ACCESSSS Smart Search
EvidenceAlerts
Evidence-Based REHAB+
Knowledge Translation+
Help
About This Site
Contact Us
Register
Log in
Login
Email
Password
Remember me?
Forgot your password?
Register for a new account
CLOT
+
See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy
Publications for Vicky Tagalakis
Updated daily
Back to Member List
Loading publication list...
Show
10
25
50
100
entries
Search:
#
PubMedId
Deleted
Publication
1
38262288
0
Abdulrehman J, Harrigan A, Simard C, et al.
TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.
Thromb Res. 2024 Jan 17;235:11-14. doi: 10.1016/j.thromres.2024.01.009.
2
37589970
0
Gulati S, Hsu CY, Shah S, et al.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
JAMA Oncol. 2023 Aug 17. doi: 10.1001/jamaoncol.2023.2934.
3
37183930
0
Aloe S, Filliter C, Salmasi S, et al.
SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study.
Br J Clin Pharmacol. 2023 May 15. doi: 10.1111/bcp.15787.
4
37121015
0
Potere N, Di Nisio M, Porreca E, et al.
Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial.
Thromb Res. 2023 Apr 26;226:82-85. doi: 10.1016/j.thromres.2023.04.015.
5
36150513
0
Douros A, Basedow F, Cui Y, et al.
Effectiveness and safety of direct oral anticoagulants among octogenarians with venous thromboembolism: an international multi-database cohort study.
Am J Med. 2022 Sep 20. pii: S0002-9343(22)00666-0. doi: 10.1016/j.amjmed.2022.08.033.
6
36100263
0
Auer RC, Ott M, Karanicolas P, et al.
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.
BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375.
7
36051542
0
Simard C, Gerstein L, Cafaro T, et al.
Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature.
Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12801. doi: 10.1002/rth2.12801. eCollection 2022 Aug.
8
35660801
0
Brandt W, Brown C, Wang TF, et al.
Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014.
9
35587536
0
Popov J, Coelho S, Carrier M, et al.
Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study.
J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760.
10
35036824
0
Douros A, Basedow F, Cui Y, et al.
Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi-database cohort study.
Res Pract Thromb Haemost. 2022 Jan 10;6(1):e12643. doi: 10.1002/rth2.12643. eCollection 2022 Jan.
Showing 1 to 10 of 33 entries
Previous
1
2
3
4
Next
×